News
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...
Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.
Latin Times on MSN2h
$50B U.S. Push Swiss Pharma Leader Roche Fights Tariff ThreatsRoche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
4h
Dealbreaker on MSNRoche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs LoomRoche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...
The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...
The Architectural League of New York announced today this year’s winners of the Architectural League Prize, now in its 44th ...
The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...
Donates also said the non-profit never had any employees, and that Granados stopped being officially involved with the ...
U.S. President Donald Trump has backed away from his threats to fire Jerome Powell after days of criticising the Federal ...
The global breast biopsy devices market is projected to witness remarkable growth over the next decade. According to the latest industry analysis, global sales of breast biopsy devices are expected to ...
European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results